AGOMAB THERAPEUTICS
AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
AGOMAB THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Ghent, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.agomab.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
136.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Microsoft Exchange Online
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-28 | Origo Biopharma | Origo Biopharma acquired by AgomAb Therapeutics | N/A |
Investors List
Asabys Partners
Asabys Partners investment in Series B - AgomAb Therapeutics
Walleye Capital
Walleye Capital investment in Series B - AgomAb Therapeutics
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative investment in Series B - AgomAb Therapeutics
Pontifax
Pontifax investment in Series B - AgomAb Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - AgomAb Therapeutics
Andera Partners
Andera Partners investment in Series B - AgomAb Therapeutics
Redmile Group
Redmile Group investment in Series B - AgomAb Therapeutics
AdBio partners
AdBio partners investment in Series B - AgomAb Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - AgomAb Therapeutics
V-Bio Ventures
V-Bio Ventures investment in Series B - AgomAb Therapeutics
Official Site Inspections
http://www.agomab.com Semrush global rank: 3.72 M Semrush visits lastest month: 3.69 K
- Host name: 20.50.64.17
- IP address: 20.50.64.17
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
